These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 528067)
1. Aryl hydrocarbon hydroxylase inducibility in lung cancer patients undergoing radiotherapy. Prasad N; Prasad R; Harrell JE; Thornby J; Liem JH; Hudgins PT; Guinn GA Int J Cancer; 1979 Oct; 24(4):415-20. PubMed ID: 528067 [TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon hydroxylase inducibility and lymphoblast formation in lung cancer patients. Prasad R; Prasad N; Harrell JE; Thornby J; Liem JH; Hudgins PT; Tsuang J Int J Cancer; 1979 Mar; 23(3):316-20. PubMed ID: 437915 [TBL] [Abstract][Full Text] [Related]
3. Distribution of aryl hydrocarbon hydroxylase inducibility in cultured human lymphocytes. Paigen B; Minowada J; Gurtoo HL; Paigen K; Parker NB; Ward E; Hayner NT; Bross ID; Bock F; Vincent R Cancer Res; 1977 Jun; 37(6):1829-37. PubMed ID: 870187 [TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls. Kärki NT; Pokela R; Nuutinen L; Pelkonen O Int J Cancer; 1987 May; 39(5):565-70. PubMed ID: 3570549 [TBL] [Abstract][Full Text] [Related]
5. Induction of aryl hydrocarbon hydroxylase activity in cultured human lymphocytes. Suolinna EM; Vänttinen E; Aitio A Toxicology; 1982; 24(1):73-84. PubMed ID: 7135405 [TBL] [Abstract][Full Text] [Related]
6. Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes. Atlas SA; Vesell ES; Nebert DW Cancer Res; 1976 Dec; 36(12):4619-30. PubMed ID: 63323 [TBL] [Abstract][Full Text] [Related]
7. Questionable relation of aryl hydrocarbon hydroxylase to lung-cancer risk. Paigen B; Gurtoo HL; Minowada J; Houten L; Vincent R; Paigen K; Parker NB; Ward E; Hayner NT N Engl J Med; 1977 Aug; 297(7):346-50. PubMed ID: 876325 [TBL] [Abstract][Full Text] [Related]
8. Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls. Guirgis HA; Lynch HT; Mate T; Harris RE; Wells I; Caha L; Anderson J; Maloney K; Rankin L Oncology; 1976; 33(3):105-9. PubMed ID: 1012643 [TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon hydroxylase inducibility is not altered in bladder cancer patients or their progeny. Paigen B; Ward E; Steenland K; Havens M; Sartori P Int J Cancer; 1979 Mar; 23(3):312-5. PubMed ID: 437914 [TBL] [Abstract][Full Text] [Related]
10. Seasonal variation of aryl hydrocarbon hydroxylase inducibility in human lymphocytes in culture. Richter A; Kadar D; Liszka-Hagmajer E; Kalow W Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):453-75. PubMed ID: 653102 [TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon hydroxylase activity in cultured lymphocytes of psoriatic patients. Kärki NT; Karvonen J; Pelkonen O Arch Dermatol Res; 1982; 273(1-2):103-9. PubMed ID: 7184465 [TBL] [Abstract][Full Text] [Related]
12. Environmental factors and aryl hydrocarbon hydroxylase activity (CYP1A1 phenotype) in human lymphocytes. Kiyohara C; Hirohata T J Epidemiol; 1997 Dec; 7(4):244-50. PubMed ID: 9465551 [TBL] [Abstract][Full Text] [Related]
14. Inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes: a study of repeatability. Fletcher KA; Evans DA; Canning MV J Med Genet; 1978 Jun; 15(3):182-8. PubMed ID: 353284 [TBL] [Abstract][Full Text] [Related]
15. The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Kiyohara C; Nakanishi Y; Inutsuka S; Takayama K; Hara N; Motohiro A; Tanaka K; Kono S; Hirohata T Pharmacogenetics; 1998 Aug; 8(4):315-23. PubMed ID: 9731718 [TBL] [Abstract][Full Text] [Related]
16. [Role of aryl hydrocarbon hydroxylase in developing laryngeal cancer among smokers]. Wu Z Zhonghua Er Bi Yan Hou Ke Za Zhi; 1991; 26(6):325-7, 381. PubMed ID: 1811685 [TBL] [Abstract][Full Text] [Related]
17. A relationship between cord blood and maternal blood lymphocytes and term placenta in the induction of aryl hydrocarbon hydroxylase activity. Pelkonen O; Karki NT; Tuimala R Cancer Lett; 1981 Jul; 13(2):103-10. PubMed ID: 7332631 [TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon hydroxylase activity in pulmonary alveolar macrophages and lymphocytes from lung cancer and noncancer patients: a correlation with family histories of cancer. McLemore TL; Martin RR; Springer RR; Wray N; Cantrell ET; Busbee DL Biochem Genet; 1979 Oct; 17(9-10):795-806. PubMed ID: 540021 [TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer. Ward E; Paigen B; Steenland K; Vincent R; Minowada J; Gurtoo HL; Sartori P; Havens MB Int J Cancer; 1978 Oct; 22(4):384-9. PubMed ID: 212378 [TBL] [Abstract][Full Text] [Related]
20. 3-Methylcholanthrene inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes depends upon the extent of blast transformation. Hart P; Cooksley WG; Farrell GC; Powell LW Biochem Pharmacol; 1977 Oct; 26(19):1831-4. PubMed ID: 907723 [No Abstract] [Full Text] [Related] [Next] [New Search]